Abstract

Toxoplasma gondii can cause congenital, neurologic, ocular, and mild or asymptomatic infection. To determine the U.S. prevalence of T. gondii infection, we tested sera collected from the National Health and Nutrition Examination Survey (NHANES) 1999–2004 for T. gondii immunoglobulin G antibodies in persons 6–49 years old and contrasted the results to those comparable in NHANES III (1988–1994) (ages 12–49 years). Of the 17,672 persons examined in NHANES 1999–2004, 15,960 (90%) were tested. The age-adjusted T. gondii seroprevalence among persons 6–49 years old was 10.8% (95% confidence limits [CL] 9.6%, 11.9%), and among women 15–44 years old, 11.0% (95% CL 9.5%, 12.4%). T. gondii seroprevalence declined from 14.1% to 9.0% ( P < 0.001) from NHANES III to NHANES 1999–2004 among U.S.-born persons ages 12–49 years. Although T. gondii infects many persons in the U.S., the prevalence has declined in the past decade.

Keywords

Toxoplasma gondiiToxoplasmosisMedicineVirologyImmunologyBiologyAntibody

Affiliated Institutions

Related Publications

Publication Info

Year
2007
Type
article
Volume
77
Issue
3
Pages
405-410
Citations
368
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

368
OpenAlex

Cite This

Jeffrey L. Jones, Deanna Kruszon-Moran, Kolby Sanders-Lewis et al. (2007). Toxoplasma gondii Infection in the United States, 1999–2004, Decline from the Prior Decade. American Journal of Tropical Medicine and Hygiene , 77 (3) , 405-410. https://doi.org/10.4269/ajtmh.2007.77.405

Identifiers

DOI
10.4269/ajtmh.2007.77.405